Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 2Diabetes Mellitus, Insulin-Dependent, 12 1

Interventions

Ipilimumab 4tremelimumab 1tilsotolimod 1durvalumab 1Vemurafenib 1Vaccination 1Surgical Procedures, Operative 1Nivolumab 1Melphalan 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Diabetes Mellitus, Insulin-Dependent, 12 × Vaccination × Clear all
NCT01216436 2015-05-25

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Duke University

Phase 1 Terminated
2 enrolled
Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡